share_log

Gossamer Bio Announced Two Oral Presentations And Poster Presentation With Data Relevant To Seralutinib At European Respiratory Society Congress 2024

Benzinga ·  Aug 27 04:02

- Additional Phase 2 TORREY Open-Label Extension Data to be Presented in Vienna -

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment